442 related articles for article (PubMed ID: 30125355)
1. Fluorescence-guided surgery for high-grade gliomas.
Lakomkin N; Hadjipanayis CG
J Surg Oncol; 2018 Aug; 118(2):356-361. PubMed ID: 30125355
[TBL] [Abstract][Full Text] [Related]
2. A prospective Phase II clinical trial of 5-aminolevulinic acid to assess the correlation of intraoperative fluorescence intensity and degree of histologic cellularity during resection of high-grade gliomas.
Lau D; Hervey-Jumper SL; Chang S; Molinaro AM; McDermott MW; Phillips JJ; Berger MS
J Neurosurg; 2016 May; 124(5):1300-9. PubMed ID: 26544781
[TBL] [Abstract][Full Text] [Related]
3. Impact of the combination of 5-aminolevulinic acid-induced fluorescence with intraoperative magnetic resonance imaging-guided surgery for glioma.
Tsugu A; Ishizaka H; Mizokami Y; Osada T; Baba T; Yoshiyama M; Nishiyama J; Matsumae M
World Neurosurg; 2011; 76(1-2):120-7. PubMed ID: 21839963
[TBL] [Abstract][Full Text] [Related]
4. 5-ALA and FDA approval for glioma surgery.
Hadjipanayis CG; Stummer W
J Neurooncol; 2019 Feb; 141(3):479-486. PubMed ID: 30644008
[TBL] [Abstract][Full Text] [Related]
5. The impact of 5-aminolevulinic acid on extent of resection in newly diagnosed high grade gliomas: a systematic review and single institutional experience.
Haider SA; Lim S; Kalkanis SN; Lee IY
J Neurooncol; 2019 Feb; 141(3):507-515. PubMed ID: 30506501
[TBL] [Abstract][Full Text] [Related]
6. 5-Aminolevulinic Acid Hydrochloride (5-ALA)-Guided Surgical Resection of High-Grade Gliomas: A Health Technology Assessment.
Ontario Health (Quality)
Ont Health Technol Assess Ser; 2020; 20(9):1-92. PubMed ID: 32194883
[TBL] [Abstract][Full Text] [Related]
7. Fluorescence image-guided neurosurgery.
Kaneko S; Eljamel MS
Future Oncol; 2017 Nov; 13(26):2341-2348. PubMed ID: 29121788
[TBL] [Abstract][Full Text] [Related]
8. Established and emerging uses of 5-ALA in the brain: an overview.
Díez Valle R; Hadjipanayis CG; Stummer W
J Neurooncol; 2019 Feb; 141(3):487-494. PubMed ID: 30607705
[TBL] [Abstract][Full Text] [Related]
9. Feasibility of fluorescence-guided resection of recurrent gliomas using five-aminolevulinic acid: retrospective analysis of surgical and neurological outcome in 58 patients.
Hickmann AK; Nadji-Ohl M; Hopf NJ
J Neurooncol; 2015 Mar; 122(1):151-60. PubMed ID: 25557106
[TBL] [Abstract][Full Text] [Related]
10. A Phase 1 Dose-Escalation Study of Oral 5-Aminolevulinic Acid in Adult Patients Undergoing Resection of a Newly Diagnosed or Recurrent High-Grade Glioma.
Cozzens JW; Lokaitis BC; Moore BE; Amin DV; Espinosa JA; MacGregor M; Michael AP; Jones BA
Neurosurgery; 2017 Jul; 81(1):46-55. PubMed ID: 28498936
[TBL] [Abstract][Full Text] [Related]
11. 5-Aminolevulinic Acid: Pitfalls of Fluorescence-guided Resection for Malignant Gliomas and Application for Malignant Glioma Therapy.
Yamamoto J; Kitagawa T; Miyaoka R; Suzuki K; Takamatsu S; Saito T; Nakano Y
J UOEH; 2020; 42(1):27-34. PubMed ID: 32213740
[TBL] [Abstract][Full Text] [Related]
12. To what extent will 5-aminolevulinic acid change the face of malignant glioma surgery?
Díez Valle R; Tejada Solis S
CNS Oncol; 2015; 4(4):265-72. PubMed ID: 26118538
[TBL] [Abstract][Full Text] [Related]
13. Fluorescence-Guided Surgery for High-Grade Gliomas: State of the Art and New Perspectives.
Palmieri G; Cofano F; Salvati LF; Monticelli M; Zeppa P; Perna GD; Melcarne A; Altieri R; La Rocca G; Sabatino G; Barbagallo GM; Tartara F; Zenga F; Garbossa D
Technol Cancer Res Treat; 2021; 20():15330338211021605. PubMed ID: 34212784
[TBL] [Abstract][Full Text] [Related]
14. 5-Aminolevulinic acid fluorescence guided surgery for recurrent high-grade gliomas.
Chohan MO; Berger MS
J Neurooncol; 2019 Feb; 141(3):517-522. PubMed ID: 30097823
[TBL] [Abstract][Full Text] [Related]
15. Randomized, Prospective Double-Blinded Study Comparing 3 Different Doses of 5-Aminolevulinic Acid for Fluorescence-Guided Resections of Malignant Gliomas.
Stummer W; Stepp H; Wiestler OD; Pichlmeier U
Neurosurgery; 2017 Aug; 81(2):230-239. PubMed ID: 28379547
[TBL] [Abstract][Full Text] [Related]
16. 5-Aminolevulinic acid fluorescence guided resection of malignant glioma: Hong Kong experience.
Chan DTM; Yi-Pin Sonia H; Poon WS
Asian J Surg; 2018 Sep; 41(5):467-472. PubMed ID: 28844780
[TBL] [Abstract][Full Text] [Related]
17. Aminolevulinic acid (ALA)-protoporphyrin IX fluorescence guided tumour resection. Part 1: Clinical, radiological and pathological studies.
Colditz MJ; Jeffree RL
J Clin Neurosci; 2012 Nov; 19(11):1471-4. PubMed ID: 22959448
[TBL] [Abstract][Full Text] [Related]
18. Identification of PEPT2 as an important candidate molecule in 5-ALA-mediated fluorescence-guided surgery in WHO grade II/III gliomas.
Hou C; Yamaguchi S; Ishi Y; Terasaka S; Kobayashi H; Motegi H; Hatanaka KC; Houkin K
J Neurooncol; 2019 Jun; 143(2):197-206. PubMed ID: 30929128
[TBL] [Abstract][Full Text] [Related]
19. Combined Use of 5-Aminolevulinic Acid and Intraoperative Low-Field Magnetic Resonance Imaging in High-Grade Glioma Surgery.
Bassaganyas-Vancells C; Roldán P; González JJ; Ferrés A; García S; Culebras D; Hoyos J; Reyes L; Torales J; Enseñat J
World Neurosurg; 2019 Oct; 130():e206-e212. PubMed ID: 31203073
[TBL] [Abstract][Full Text] [Related]
20. 5-ALA in the management of malignant glioma.
Stepp H; Stummer W
Lasers Surg Med; 2018 Jul; 50(5):399-419. PubMed ID: 29737540
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]